BRIEF published on 04/10/2026 at 17:50, 5 months 1 day ago Eurobio Scientific Reports prévoit une augmentation de 9 % de son chiffre d'affaires en 2025 Expansion Internationale Marge Brute Bénéfice Net Produits Exclusifs Revenus Annuels
BRIEF published on 04/10/2026 at 17:50, 5 months 1 day ago Eurobio Scientific Reports 9% Revenue Increase for 2025 Gross Margin International Expansion Net Profit Annual Revenue Proprietary Products
PRESS RELEASE published on 04/10/2026 at 17:45, 5 months 1 day ago EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS Eurobio Scientific reports 9% revenue growth in 2025, with 20% increase in proprietary product sales and 42% international revenue. Strategic plan execution reflected in annual results Revenue Growth Strategic Plan Internationalisation Eurobio Scientific Proprietary Products
BRIEF published on 05/19/2025 at 19:21, 1 year 3 months ago EB Development dépasse les 90 % du capital d'Eurobio Scientific Diagnostic In Vitro Réunion Financière Eurobio Scientific Développement EB 90 % Des Actions
BRIEF published on 05/19/2025 at 19:21, 1 year 3 months ago EB Development Surpasses 90% Stake in Eurobio Scientific In Vitro Diagnostics Eurobio Scientific EB Development Financial Meeting 90% Shareholding
PRESS RELEASE published on 05/19/2025 at 19:16, 1 year 3 months ago Eurobio Scientific: EB Development rises above 90% threshold Eurobio Scientific's shareholder EB Development surpasses 90% share capital threshold through market acquisitions. Financial meeting: Annual General Meeting on June 19, 2025 Share Capital Eurobio Scientific EB Development Financial Meeting 90% Threshold
PRESS RELEASE published on 05/19/2025 at 19:16, 1 year 3 months ago Eurobio Scientific : EB Development franchit à la hausse le seuil de 90% EB Development franchit à la hausse le seuil de 90% du capital d'Eurobio Scientific suite à une acquisition d'actions sur le marché. Prochain rendez-vous financier : Assemblée générale le 19 juin 2025 Franchissement De Seuil Assemblée Générale Diagnostic Médical Eurobio Scientific EB Development
BRIEF published on 04/29/2025 at 21:05, 1 year 4 months ago Mise à disposition du rapport financier annuel 2024 par Eurobio Scientific Diagnostic In Vitro Assemblée Générale Investisseurs Rapport Annuel 2024 Eurobio Scientific
BRIEF published on 04/29/2025 at 21:05, 1 year 4 months ago Availability of the 2024 annual financial report by Eurobio Scientific Investors In Vitro Diagnostics General Meeting Annual Report 2024 Eurobio Scientific
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year 4 months ago Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Eurobio Scientific annonce la mise à disposition de son rapport financier annuel 2024 auprès du public et de l'AMF Assemblée Générale Investisseurs Rapport Financier Annuel Diagnostic Médical Eurobio Scientific
Published on 09/12/2026 at 02:35, 11 hours 21 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 56 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 51 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 31 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 56 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 25 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 41 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 45 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 11 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 40 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
